Influenza A Infections Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Influenza A Infections Market is segmented By Therapeutic Product (Prophylactic treatments, Antivira...

Influenza A Infections Market Size

Market Size in USD Mn

CAGR2.7%

Study Period2024 - 2031
Base Year of Estimation2023
CAGR2.7%
Market ConcentrationMedium
Major PlayersCidara Therapeutics, SAb Biotherapeutics, FluGen, Moderna, Vir Biotechnology and Among Others
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Influenza A Infections Market Analysis

The influenza A infections market is estimated to be valued at USD 723.2 Mn in 2024 and is expected to reach USD 873.4 Mn by 2031, growing at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031. Widespread initiatives by governments and private organizations to increase vaccination rates along with rising awareness about preventive healthcare have contributed to the market growth.

Influenza A Infections Market Report Snapshots